Dr Sandra Salter is a Senior Lecturer in Pharmacy Practice.

Dr Salter has been active in anaphylaxis research since 2011. She is a member of the Australasian Society of Clinical Immunology and Allergy (ASCIA) and works closely with the National Allergy Council and ASCIA in the fields of anaphylaxis and food allergy research. Dr Salter is the first researcher worldwide to utilise multiple linked datasets in anaphylaxis epidemiology research. 

In 2020, in collaboration with Industry partners SmartVax and MedAdvisor and supported by a $40,000 grant from the JM O'Hara Research Fund, Dr Salter developed and piloted an active vaccine safety surveillance program for patients immunised in pharmacies. This system was expanded in 2021 to facilitate the safe deployment of COVID-19 vaccines, supported by a $217,000 grant from WA Health. As a result of this research, people vaccinated in community pharmacies across Australia are now included in AusVaxSafety's national vaccine safety monitoring system, not just for COVID-19 vaccines, but for all vaccines. 

In addition to her academic role, Dr Salter has experience in private and public hospital, general practice and community pharmacy. She is an experienced clinical pharmacist, with substantial experience in leadership, pharmacy and business management, in Chief Pharmacist (Hospital) and Managing Pharmacist (community) roles.  Dr Salter has more than 25 years experience in teaching across a wide variety of settings, including university, hospital, community pharmacy, general practice, Intern training, and other medical, healthcare and individual patient settings.

Dr Salter was awarded Fellowship of the Pharmaceutical Society of Australia in 2023 in recognition of her long-standing commitment to the profession. 

Chief Investigator on the following projects:

• COVID-19 Vaccine Safety Monitoring in Community Pharmacy (COVID-19 VIP)
• Actively Monitoring the Safety of Immunisation in Community Pharmacies in Western Australia (AIM-CP)
• Epidemiology of Anaphylaxis in Western Australia (EPAWA) 
• Paediatric Eczema Model of Care for Pharmacists (PEMCP)

Supervision of the following PhD projects: 

• Anaphylaxis epidemiology and characteristics
• Public health approach to food allergy prevention
• Professionalism in pharmacy
• Optimising anticoagulation among patients with atrial fibrillation in general practice

Key research collaborations: 

• National Allergy Council (including member of the expert NAC Drug Allergy Working Group)
• Department of Allergy, Immunology and Dermatology at Perth Childrens’ Hospital.
• AusVaxSafety/NCIRS
• SmartVax
• MedAdvisor

National Allergy Council - expert Drug Allergy Working Group

ASCIA Anaphylaxis Committee

Faculty of Health and Medical Sciences Research Committee: previous SAH Representative 

School of Allied Health Research Committee: previous Co-Chair

Unit Coordination

PHCY5630: Integrated Pharmacology, Therapeutics and Pharmacy Practice 3

PHCY5613: Management and Economics in Pharmacy